Macrophages as effectors of autoimmune valvular carditis

巨噬细胞作为自身免疫性瓣膜性心脏病的效应器

• 批准号: 8890874
• 负责人: Bryce Binstadt
• 金额: $ 36.6万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-15 至 2019-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8890874
• 关键词: Adult; Affect; Animal Model; Anti-Inflammatory Agents; Anti-inflammatory; Antigen-Antibody Complex; Arthritis; Attention; Autoantibodies; Autoimmune Diseases; Autoimmune Process; Automobile Driving; B-Lymphocytes; Biological Models; Biology; CD4 Positive T Lymphocytes; Cardiovascular Diseases; Cardiovascular system; Carditis; Cell Differentiation process; Cell Surface Receptors; Cells; Chronic; Data; Deposition; Disease; Equilibrium; Fc Receptor; Fibrosis; Genes; Goals; Health; Heart Valves; Human; Immunoglobulin G; Infiltration; Inflammation; Inflammatory; Inflammatory Response; Injury; Integrin alpha4beta1; Interferon Type II; Interleukin-1; Interleukin-17; Interleukin-18; K/BxN model; Knowledge; Lead; Lupus; Macrophage Activation; Mediating; Methods; Modeling; Molecular; Morbidity - disease rate; Myeloid Cells; Outcome; Pathogenesis; Pathology; Pathway interactions; Patients; Phenotype; Play; Population; Production; Receptor Signaling; Recruitment Activity; Relative (related person); Rheumatism; Rheumatoid Arthritis; Role; Severities; Severity of illness; System; Systemic Lupus Erythematosus; T-Lymphocyte; TLR4 gene; TNF gene; Testing; Tissues; arginase; autoimmune arthritis; autoreactivity; burden of illness; cell type; chronic autoimmune disease; cytokine; improved; in vivo; insight; knockout animal; macrophage; monocyte; mortality; mouse model; neutrophil; novel; systemic autoimmune disease; toll-like receptor 4; tool

DESCRIPTION (provided by applicant): Our long-term goal is to understand how cardiovascular tissues are targeted for attack in the context of systemic autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. In this proposal we focus on macrophages, a key inflammatory cell type. Although the presence of macrophages in inflamed cardiovascular tissues in patients with these diseases has long been recognized, the tools to dissect their precise role in disease pathogenesis have only recently been developed. We propose to employ these powerful new tools to study how macrophages contribute to cardiovascular inflammation in the setting of systemic rheumatic diseases. We have recently described the occurrence of cardiac valve inflammation in a mouse model of autoimmune arthritis. Valvular carditis in this model is similar to that seen in rheumatic diseases in humans. The cytokine interleukin-17 (IL-17) and immune complexes interacting with activating Fc receptors are critical for carditis to develop. Importantly, macrophages are the predominant inflammatory cell type in this model. Macrophages are characterized broadly as M1 (classical/pro-inflammatory) or M2 (alternative/anti-inflammatory). Our preliminary data suggest that both of these populations may contribute to valvular carditis. We propose to study essential aspects of macrophage biology in this model system: entry into the cardiovascular tissue, activation, and effector function. First, we will determine how macrophages enter the cardiac valves, focusing on the cell surface receptor VLA-4. Next, we will explore how IL-17, activating Fc receptors and TLR4 drive macrophage activation toward M1 or M2 phenotypes. We will then dissect the relative contributions of the M1 and M2 macrophage populations to disease severity, by interfering with the differentiation of these cell subsets or with their key molecular products. Using recently-developed conditional gene knockout animals in conjunction with more traditional methods will allow us to interrogate the pathogenic mechanisms employed by macrophages in this system. Immune complexes, IL-17, and macrophage infiltration are hallmarks of many human autoimmune diseases. We propose to use our novel animal model system to begin to understand how these molecules and cells interact in vivo to provoke tissue pathology, with specific attention to the cardiac valves. The knowledge that we gain is expected to lead to new therapies to reduce the cardiovascular morbidity and mortality among patients with rheumatoid arthritis, lupus, and related autoimmune conditions.

描述（由申请人提供）：我们的长期目标是了解在系统性自身免疫性疾病（如类风湿关节炎和系统性红斑狼疮）的背景下，心血管组织是如何被靶向攻击的。在这个建议中，我们关注巨噬细胞，一种关键的炎症细胞类型。虽然巨噬细胞在这些疾病患者的炎症心血管组织中的存在早已被认识到，但剖析其在疾病发病机制中的精确作用的工具直到最近才被开发出来。我们建议使用这些强大的新工具来研究巨噬细胞如何在系统性风湿性疾病的背景下促进心血管炎症。我们最近描述了自身免疫性关节炎小鼠模型中心脏瓣膜炎症的发生。该模型中的瓣膜性心炎与人类风湿性疾病中的瓣膜性心炎相似。